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Abstract
Background: Apart from localized gastrointestinal infections, Escherichia coli and Salmonella species are major
causes of systemic disease in both humans and animals. Salmonella spp. cause invasive infections such as enteric
fever, septicemia, osteomyelitis and meningitis while certain types of E. coli can cause systemic infections, including
pyelonephritis, meningitis and septicemia. These characteristic requires the involvement of a myriad of virulence
factors.
Methods: This study investigated the virulence factors of Escherichia coli and Salmonella species in clinical
specimens from patients with diarrhoea presenting to health care centres in Oliver R. Tambo District Municipality,
Eastern Cape Province, Republic of South Africa. Microbiology analysis involved the use of cultural and molecular
techniques.
Results: Out of a total of 315 samples screened, Salmonella isolates were obtained in 119 (37.8%) of cases and
these comprised: S. choleraesuis (6%), S. enteritidis (4%), S. eppendorf (1%), S. hadar (1%), S. isangi (8%), S. panama
(1%), S. typhi (52%), S. typhimurium (25%) and untyped Salmonella spp. (2%). Among the Salmonella species 87
(73.1%) were invasive. Using molecular diagnostic methods, diarrheagenic E. coli were detected in 90 cases (28.6%):
the greater proportion of this were enteroaggregative E. coli (EAEC) 37 (41.1%), enteropathogenic E. coli (EPEC) 21
(23.3%) and enterohemorrhagic E. coli (EHEC) 21 (23.3%). The predominant virulence gene among the
diarrheagenic E. coli was EAEC heat-stable enterotoxin astA genes while the virulence genes identified in the
Salmonella strains were 15 (12.6%) flic and 105 (88.2%) inv genes. The amino acid identity of the representative
genes showed 95-100% similarity to corresponding blast searched sequence.
Conclusions: This study showed the diversity of virulence gene expression in two major enteric pathogens. S. typhi
and enteroaggregative E. coli were the predominant enteropathogens in our study area with an indication that
EAEC is endemic within our study population. It was observed among other things that some diarrheagenic E. coli
isolated from apparently asymptomatic subjects expressed some virulence genes at frequency as high as seen in
diarrheagenic cases. This study underlines the importance of understanding the virulence composition and
diversity of pathogens for enhanced clinico-epidemiological monitoring and health care delivery.
Background
Gastrointestinal infections due to pathogenic Enterobac-
teriaceae in particular Escherichia and Salmonella spe-
cies are significant causes of morbidity and mortality
worldwide. These infections which usually are self-limit-
ing may be fatal in hosts with debilitating immune
systems [1]. The fatality of infections due to these
enteric pathogens depends on their serotypes, the size of
the inoculum, and the status of the host [2]. Escherichia
and Salmonella species were reported to have diverged
from a common ancestor based on the evolutionary rate
estimates from 5S and 16S rRNA sequence analyses
while Shigella spp. are considered clonal lineages of
Escherichia coli [3]. Salmonella species are mainly
pathogenic, with differing host ranges. S. typhi is
adapted to humans and does not occur in animals while
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non-typhoidal Salmonella serovars (NTS) have a broad
vertebrate host range [2]. Even though E. coli is gener-
ally known as commensal normal flora of the gut, some
E. coli strains are the causative agents of neonatal
meningitis, urinary tract infections, bacteremia, and
infectious diarrhea.
The major distinguishing factor between pathogenic
and non-pathogenic strains of E. coli strains is the
occurrence of virulence genes, which code for the var-
ious known strategies for pathogenecity. Analysis have
shown that pathogenic E. coli strains from diarrhoea
cases and those involved in urinary tract infections are
more of a distinct subsets of E. coli, rather than a reflec-
tion of the random fecal flora [4]. Some of the virulence
factors of E. coli include ability to adhere, colonize, and
invade the hosts’ cells. Further to these are the secretion
systems, production of cell surface molecules, transport
and siderophore formation [5]. According to Kaper et
al., [6], E. coli has been categorized based on the type of
virulence factors present and host clinical symptoms
basically into the following pathotypes: enteropathogenic
E. coli (EPEC); enterohemorrhagic E. coli (EHEC); enter-
otoxigenic E. coli (ETEC); enteroaggregative E. coli
(EAEC) and diffusely adherent E. coli (DAEC), a sub-
class of enteroaggregative E. coli; enteroinvasive E. coli
(EIEC); uropathogenic E. coli (UPEC) and neonatal
meningitis E. coli (NMEC).
The ability of the enteric pathogen to invade and
penetrate intestinal epithelial cells is required in salmo-
nellosis whether it is confined as the intestinal form or
progresses to systemic involvement [7]. The attribute to
direct their internalization by the epithelial cells which
are not normally phagocytic is a striking Salmonella-
host cell interaction. According to Galan and Curtiss [8]
this remarkable phenotype known as invasion allowed
for identification and characterization of invasion genes.
The key mechanism involves type III secretion systems
which are encoded by pathogenicity island 1 (SPI-1) [9].
Salmonella also possess the ability to alter phagocytosis
in order to circumvent the process. S. enterica serovar
Typhimurium is known to delay significantly the fusion
of the phagosome to the lysosome [10]; thereby hiber-
nating in phagocytic cells and hence adapt to resist the
antimicrobial activity of the fused phagolysosome [11].
Bacterial survival in phagocytic cells has been observed
as an alternate to invasion in accessing privileged sites
in hosts. Rescigno et al., [12] postulated that CD18+
expressing phagocytes are alternate route and these cells
have been observed by Vasquez-Torres et al., [13] as
vehicles for reaching the spleen in an invasion-indepen-
dent manner by S. enterica serovar Typhimurium.
Molecular analysis is known to give a better picture of
epidemiology of infectious diseases. Studies have
demonstrated the sensitivities of molecular-based
methods to be greater compared to current conventional
methods of analysis [1]. Molecular studies have led to
the understanding of the genomic make-up of bacteria
which generally consist of stable regions and variable
regions, the flexible part that is composed of bacterio-
phages, plasmids, transposons as well as unstable large
regions, called genomic islands. The so-called genomic
islands are a gene pool required for encoding virulence
factors of pathogenic bacteria and these have been
designated “pathogenicity islands” [14]. The concept of
pathogenicity islands (Pais) was first identified through
the genetic and molecular analysis of virulence genes in
uropathogenic E. coli and EPEC [15]. Pais which are
specific regions of chromosomal DNA have been
described in more than 30 bacterial species [14]. It is a
well known concept that bacterial pathogenicity is an
organized multifactorial process involving numerous
chromosomal and extrachromosomal genes directed by
complex regulatory circuits [16,17].
There are various shared genetic strategies for patho-
genicity in enteric bacilli. Type III secretion is a dedi-
cated secretion machinery whose components are coded
for by numerous homologous gene sequences shared by
enteric pathogens [3,18]. Nevertheless, there has been
understanding that the similarities between EPEC viru-
lence attributes and Salmonella invasion genes are more
than homologous genes associated with secretion [19].
Most virulence factors of pathogenic E. coli, Shigella,
and Salmonella strains are plasmid-borne however; one
or more of the essential virulence determinants are
borne on an extrachromosomal element [20]. In both E.
coli and Salmonella spp. fimbriae might play a role in
adhesion and invasion [21]. The curli fimbriae of these
strains were proven to bind to several tissue-matrix pro-
teins as well as plasminogen and its activator t-PA [3].
Bacteria are emerging with new means of circumvent-
ing human efforts at curbing their nefarious schemes
and various evolvement patterns and innovations are
certainly put in place by these pathogens. A myriad
combination of virulence genes against indiscriminate
genetic transfer and recombination are required for a
successful emergence of pathogen [22,23]. Profiling the
expression of these genes will give impetus to under-
standing the mechanisms by which enteric bacterial
pathogens colonize, spread and at times persist in the
hosts [24]. This study investigated the genetic determi-
nants of virulence in E. coli and Salmonella spp. which
are significant pathogens involved in enteric diseases.
Methods
Specimens’ collection and bacterial isolation
The study is a retrospective and cross-sectional study
which utilized data originally collected for surveillance
purposes focusing on Nelson Mandela Academic
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Hospital Complex (NAMHC), Mthatha, a health facility
which serve as a referral hospital in the Eastern Cape
Province of South Africa. Specimens’ collection from
cases was from both male and female diarrhoeic patients
from all age categories and was based on availability.
Written informed consent was obtained from all
patients, parents or guardians as the case may be and
questionnaire was administered by trained volunteer
health workers. Information provided include the fre-
quency of episodes of diarrhoea and whether or not
antibiotic or other forms of medication has been used.
The control specimens were then selected from the
group which had not had diarrhea or antibiotic therapy
in the preceding 2 weeks. The study protocol and data
handling were approved by the WSU ethics committee
(Protocol No. 0003/08) as well as the Department of
Health, Eastern Cape, South Africa.
Salmonella isolates deposited at the NICD, Johannes-
burg under the surveillance study of 2005 to 2008 from
this tertiary health facility were obtained. For 2009 fresh
stool samples in sterile stool jar or rectal swabs in Cary-
Blair transport medium per patient were collected from
125 patients presenting with acute diarrhoea in the ter-
tiary referral facility and surrounding clinics and 75
apparently healthy school pupils in three different
schools within ORTDM. These were transported on ice
pack to the laboratory where analysis was done within
24 hours. Where this is not possible specimen were pre-
served at temperature between 4 to 8°C.
Bacteriological analyses
NICD isolates
Bacteriological analyses of the specimens for these iso-
lates were carried out at the National Health Laboratory
Services, Nelson Mandela Academic Hospital, Mthatha.
Samples were examined for the presence of E. coli, Sal-
monella and Shigella using standard conventional meth-
ods according to Forbes et al., [25].
E. coli
The faecal samples were cultivated on MacConkey agar.
After overnight incubation at 37°C, lactose fermenting
colonies (LFC) with the typical appearance of E. coli
were selected for further analysis. Isolates were identi-
fied by biochemical assays using Microscan Gram nega-
tive combo panel NUC 45 (Siemens/Dade Behring).
Salmonella and Shigella
Specimens were cultivated for the isolation of Salmo-
nella and Shigella species on MacConkey agar. After 24
h of incubation at 37°C, suspected colonies with typical
characteristics of Salmonella and Shigella were sub-cul-
tured on XLD (xylose lysine deoxycholate) agar for 24 h
at 37°C. Confirmation was carried out using Microscan
Gram negative combo panel NUC 45 (Siemens/Dade
Behring).
DNA extraction
DNA template for PCR was obtained from pure over-
night bacterial culture using Fungal/Bacterial DNA
extraction kit™ (Zymo Research) and following manu-
facturer’s instructions. The concentration of the eluted
DNA was measured using NanoDrop 2000 spectrophot-
ometer (Thermo Scientific).
DNA amplification
PCR amplifications were performed in a final volume of
25 μℓ containing: 0.5 to 2 μℓ of DNA template depending
on concentration, 8.5 to 10 μℓ of Nuclease free water, 1
μℓ of each primer and 12.5 μℓ Master mix (EconoTaq
Green, Fermentas). Amplifications were carried out in a
GeneAmp PCR System 9700 Thermocycler (Applied Bio-
systems). All oligonucleotide primers were synthesized by
Inqaba Biotechnology (Pretoria, South Africa) and the
sequences are as shown in Table 1 (63-72). The PCR
cycling conditions for the E. coli strains consisted of 95°C
for 5 min while for the Salmonella isolates consisted of
95°C for 1 min, which were followed by 40 cycles of
denaturation at 95°C for 30 s, annealing at 60°C for 30 s,
and elongation at 72°C for 30 s. Amplification products
were separated by electrophoreses on 10 mg/ml agarose
gel (TopVision TM, Fermentas) in 1× TBE Buffer and
ethidium bromide (5 μℓ) with a 100-bp ladder (Fermen-
tas) as molecular weight marker.
Sequencing reaction
PCR products were sequenced using an Applied Biosystems
3500xL Genetic analyzer (AB Biosystems). Prior to PCR
products sequencing, the unincorporated dNTPs were
dephosphorylated with a commercial kit from Zymo
Research Corporation (Orange, CA). Subsequently, the
PCR products were sequenced with the ABI PRISM BigDye
terminator cycle sequencing ready reaction kit (AB Biosys-
tems) using the same primers as employed in the PCR reac-
tions. The products were then subjected to the following
conditions: 94°C for 2 min, followed by 40 cycles of dena-
turation at 85°C for 1 s, annealing at 53°C for 10 s and
extension at 60°C for 2 min 30 s, with a final extension at 4°
C for 0 s. The sequencing reaction products were cleaned
up using ZR-96 DNA sequencing clean-up kit™. There-
after, the ultra-pure products were analyzed on the sequen-
cing machine. Sequences were aligned with known E. coli
and Salmonella virulence gene sequences by a blast search
of the National Center for Biotechnology Information
(NCBI) data base http://www.ncbi.nlm.nih.gov/BLAST/
using Staden package version 1.6.0-beta4 (MRC.WTSI).
Results
Demographic features
Patients’ data were analyzed using Microsoft Excel ver-
sion 2003. Continuous variables were summarized as
Bisi-Johnson et al. Gut Pathogens 2011, 3:9
http://www.gutpathogens.com/content/3/1/9
Page 3 of 8
mean. Our subjects were predominated by male patients
165/315 (52.4%) and no age group was excluded, with
the youngest patient being 3 months and the oldest 91
years. A sizeable number of cases, 95 (30.15%) were
between the ages 7 to 13 and controls school-aged 7 to
12 were matched for this age category.
Bacteriological identification and Molecular analysis
Results showed that Salmonella strains were isolated
from 119 (37.8%) of cases while diarrheagenic E. coli
was found in 90 (28.6%) of cases. The distributions of
the different pathotypes are as shown in Figures 1 and
2. Of the Salmonella isolates 87 (74.1%) were invasive.
The most common virulence factors detected among
the Salmonella strains were invA found in 105 Salmo-
nella spp. and fliC genes detected in 15 Salmonella iso-
lates. The predominant virulence gene among the
diarrheagenic E. coli was 24 EAEC heat-stable entero-
toxin astA genes. Table 2 showed the distribution of the
various genes among cases and controls. The represen-
tative gels for PCR amplification of DNA extracted from
selected E. coli and Salmonella isolates showing the pre-
sence of diverse virulence genes are indicated in addi-
tional files 1A, B and 2 respectively. One hundred and
eighty isolates were obtained from the 150 control
subjects. E. coli was the predominant bacterial species
being 85 (47.2%) while Salmonella spp. was 8 (12.1%).
Other recovered bacteria species were Proteus mirabilis
45 (25.0%), Klebsiella pneumoniae 23 (12.8%) and Enter-
obacter cloacae 19 (10.5%). The sequencing analysis of
our genes showed 100% conformation of the various
virulence genes with corresponding blast search
sequence and confirmed the strain.
Table 1 Primer sets for the pathotypes and virulence genes for the E. coli and Salmonella spp
Isolate species/subgroups Target gene Primer Nucleotide Sequence (5’- 3’) Amplicon size (bp) Reference
E. coli
EPEC and EHEC eaeA EAE-a ATGCTTAGTGCTGGTTTAGG 248 [63]
EAE-b GCCTTCATCATTTCGCTTTC
EHEC stx1 JMS1-F GTCACAGTAACAAACCGTAACA 95 [64]
JMS1-R TCGTTGACTACTTCTTATCTGGA
ETEC LT LT-1 AGCAGGTTTCCCACCGGATCACCA 132 [65]
ST LT-2 GTGCTCAGATTCTGGGTCTC 190 [66]
STa-F GCTAATGTTGGCAATTTTTATTTCTGTA
STa-R AGGATTACAACAAAGTTCACAGCAGTAA
EAEC aggR AggRks1 GTATACACAAAAGAAGGAAGC 254 [67]
astA aggRkas2 ACAGAATCGTCAGCATCAGC 106 [68]
EAST-1S GCCATCAACACAGTATATCC
EAST-1AS GAGTGACGGCTTTGTAGTCC
EIEC VirA virA-F CTGCATTCTGGCAATCTCTTCACA 215 [69]
virA-R TGATGAGCTAACTTCGTAAGCCCTCC
Salmonella
invA invA 139 GTGAAATTATCGCCACGTTCGGGCAA 284 [70]
invA 141 TCATCGCACCGTCAAAGGAACC
sefA S1 GCC GTA CAC GAG CTT ATA GA 250 [71]
S4 ACC TAC AGG GGC ACA ATA AC
fliC Fli15 CGG TGT TGC CCA GGT TGG TAA T 620 [72]
Typ04 ACT GGT AAA GAT GGC T
flic-flagellin H1; invA-invasion; sefA- fimbrial antigen; aggR- transcriptional activator for EAEC aggregative adherence fimbria I expression; eaeA-E. coli attaching
and effacing; astA-EAEC heat-stable enterotoxin; LT- heat-labile enterotoxin; ST- heat-stable enterotoxin; VirA-virulence plasmid.
Figure 1 Frequency distribution of the various Salmonella
isolates. S = Salmonella.
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Discussion
Gastroenteritis is a major concern in sub-Saharan Africa
as with other developing countries [26]. South African
National Burden of Disease study of the year 2000
found that diarrhoea accounted for nearly 3% of all
deaths in South Africa [27]. According to the South
African health review of 2007, death due to gastroenteri-
tis among children was put at 15% [28] showing increas-
ing mortality. The developed countries are not spared in
the global burden of enteric-related diarrhoea. Salmonel-
losis was considered a major public health problem in
the United States [29]. E. coli and Salmonella are among
the bacterial pathogens implicated in gastroenteritis.
These enteric pathogens have evolved different strategies
for subverting normal host cellular functions [30]. These
pathogens cause various intestinal and extraintestinal
diseases by means of virulence factors that affect a wide
range of cellular processes. These virulence induced
infections usually involve complex mechanisms with
various specific, interdependent interactions between
hosts and pathogens [31]. This present study provides
information on the pathotypes and some virulence fac-
tors associated with local isolates of E. coli and Salmo-
nella species. E coli are more than just a harmless
intestinal microflora; it can also be a highly versatile,
and frequently deadly, pathogen [6]. E. coli strains cause
diarrhoea by several distinct pathogenic mechanisms
and differ in their epidemiology. Virulence genes were
expressed in diarrheagenic E. coli from both cases and
controls. EAEC was detected in 37 (41.1%) cases invol-
ving diarrhoegenic E. coli. Studies conducted in Thai-
land and Brazil, reported a frequency of 12% and 11%
EAEC respectively among children with acute diarrhoea
[32,33]. Although the prevalence of EAEC is believed to
be considerably higher in the developing countries com-
pared to industrially developed countries, a Switzerland
study, reported that EAEC was encountered in a signifi-
cant proportion of diarrhoea cases among children [34].
As evident in this study and previous studies, EAEC
seems to be endemic within our study population and
other locations in sub-Saharan Africa [35,36], emerging
as a significant diarrheal agent worldwide with the pat-
tern of infection changing from persistent diarrhoea to
include acute diarrhoea [37].
The second diarrheagenic E. coli type detected was
EHEC constituting 21 (23.3%) of all diarrheagenic E.
coli. Enterohaemorrhagic E. coli (EHEC) is a subset of
Shiga toxin-producing Escherichia coli (STEC) which is
associated with severe systemic disease as haemorrhagic
colitis, haemolytic-uremic syndrome (HUS) and throm-
botic thrombocytopenic purpura, particularly in infants,
young children and in the elderly [38,39]. EHEC infects
the large bowel and inflict damage to the colon with
infectious dose estimated to be less than 100 CFU [40].
Of the various virulence factors associated with patho-
genicity in the EHEC strain, this study failed to detect
both Shiga toxin 1 (stx1) and Shiga toxin 2 (stx2) but
only detected intimin which is encoded by the eaeA
gene [41]. Intimin is known to facilitate the adherence
of pathogen to intestinal villi producing attaching and
effacing lesions [42]. Previous studies have implicated
EHEC in outbreaks and sporadic infections both in the
United States and around the world [43,44].
Intimin (eaeA) gene was also detected in 21 (23.3%) of
EPEC. Unlike most studies where ETEC often take the
lead in bacterial enteritis due to E. coli, a study by Weg-
gerhof [45] also reported a higher incidence of EPEC
from the screening of some pediatric patients with diar-
rhoea in Mpumalanga Province of South Africa. More
recent studies described the contributions of EPEC to
the human disease burden as significant [6,46]. Thus
EPEC plays a vital role in acute diarrhoea. EPEC is
Figure 2 Frequency distribution of the diarrheagenic E. coli
isolates. EPEC = Enteropathogenic Escherichia coli; EHEC =
Enterohemorrhagic E. coli: EAEC = Enteroaggregative E. coli:
Enterotoxigenic E. coli: EIEC = Enteroinvasive E. coli.
Table 2 Distribution of virulence genes among the E. coli and Salmonella spp
Bacterial Strain Number of isolate Virulence genes
fliC invA sefA aggR eaeA EAST LT ST virA
Salmonella spp. (case) 119 15 105 0 ND ND ND ND ND ND
Salmonella (control) 8 0 7 0 ND ND ND ND ND ND
E coli (case) 90 ND ND ND 13 21 24 5 0 2
E coli (control) 85 ND ND ND 10 11 19 0 0 0
ND-Not determined.
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known to cause illness manifesting as watery diarrhoea
with little inflammation of the intestinal mucosa [47].
Virulence is initiated in EPEC by the induction of a
characteristic ultrastructural lesion in which the bacteria
make intimate contact with the apical plasma mem-
brane, causing localized destruction of the intestinal
brush border and distortion of the apical enterocyte
membrane [48] as is in the classical attaching and effa-
cing (AE) lesion.
The ETEC and EIEC strains were found only in 9
(10.0%) and 2 (2.2%) of cases with diarrheagenic E. coli
respectively. Although ETEC strains have been described
as a major contributor to infantile diarrhoea in develop-
ing countries and of travellers’ diarrhoea in visitors to
these countries [49,50], our findings were different
showing a decline in the involvement of these strains in
our setting. ETEC strains cause secretory diarrhoea
similar to that of Vibrio cholerae by forming plasmid
encoded heat-labile (LT) or heat-stable (ST) enterotox-
ins genes [47,51]. ETEC engage strain-specific antigenic,
hair-like fimbriae in attachment to specific receptors on
the surface of enterocytes in the intestinal lumen [50].
EIEC on the other hand produce dysentery-like diar-
rhoea similar to that caused by Shigella species by
invading and multiplying within epithelial cells of the
colonic mucosa, resulting in an intense inflammatory
response characterized by abscesses and ulcerations that
damage the integrity of the epithelial cell lining of the
colon [52]. EIEC was not a major enteric bacterial
pathogen observed in this study, the prevalence was the
least (2.2%) and this was similar to that obtained in the
study conducted in Mexico City by Paniagu et al., [53]
where EIEC was the least detected in the patient group
(1%). This pattern is not consistent with studies in other
developing countries where EIEC strains were important
causes of pediatric diarrhea and dysentery [54,55].
Salmonella species are an important cause of varying
food and water-related infections. This study detected
Salmonella as a major cause of gastroenteritis in our
setting. Salmonella has previously been described as one
of the common causes of gastroenteritis particularly in
the developing countries [56,57]. On the contrary, infec-
tious diarrhoea in the developed world is often due to
viruses [58]. The most common species isolated in this
study were S. typhi (52%) and S. enterica serovar Typhi-
murium (25%). This report is consistent with other stu-
dies conducted in Iran and South Africa where S. typhi
and S. enterica serovar Typhimurium were described as
major aetiological agents of infectious diarrhoea [58,59].
S. enterica serovar Isangi was third in ranking of fre-
quency of isolation. Kruger et al., [60] described the
increasing importance of this serotype of non-typhoidal
Salmonella (NTS) which was a rare serotype in South
Africa until 2002. Other species identified were S.
enterica serovar Choleraesuis, S. enterica serovar Enteri-
tidis, S. enterica serovar Eppendorf, S. enterica serovar
Hadar, S. enterica serovar Panama and untyped Salmo-
nella spp. The virulence factor detected among the
majority (105) of the Salmonella spp. was invA. This
gene which is chromosomally located aids attachment of
the pathogen to the epithelial cells [8]. The other detect-
able virulent gene was flic detected in 15 isolates. The
flagellin gene, fliC is known to aid systemic spread of
pathogen and is specific for S. enterica serovar Typhi-
murium [61]. Enteric bacteria possessing sefA which
encodes the SEF14 fimbrial antigen, a virulence plasmid
specific for S. enterica serovar Enteritidis [62] were not
encountered jn this study.
Conclusions
This study showed the diversity of virulence gene
expression in two major enteric pathogens. It was
observed among other things that some diarrhoegenic E.
coli isolated from apparently asymptomatic subjects
expressed some virulence genes at frequency as high as
seen in diarrhoegenic cases. This is a pointer to the fact
that asymptomatic individuals serve as reservoirs of
pathogenic strains of enteric bacteria and may play a
role in the spread and acquisition of virulence genes.
Additional material
Additional file 1: Representative gels for PCR amplification of DNA
extracted from selected E. coli isolates showing the presence of
diverse virulence genes. A: 100 bp molecular weight marker (lanes 1
and 10), fragment from aggR (lanes 2 to 4), eaeA (lanes 5 to 6) and astA
(lanes 7 to 9). B: 100 bp molecular weight marker (lanes 1 and 6),
fragment from aggR (lanes 2 to 3), virA (lanes 4) and LT (lanes 5). The
relative positions in the gel of predicted size of PCR products are
indicated by arrowheads on the right sides.
Additional file 2: Representative gels for PCR amplification of DNA
extracted from selected Salmonella isolates showing the presence
of diverse virulence genes. 100 bp molecular weight marker (lanes 1
and 8) fliC (lanes 2 to 4) and invA (lanes 5 to 7). The relative positions in
the gel of predicted size of PCR products are indicated by arrowheads
on the right sides. The relative positions in the gel of predicted size of
PCR products are indicated by arrowheads on the right sides.
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